Abiopharma

Aptar - Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Director BREEN EDWARD D 🔴 sold 24.6K shares of DuPont de Nemours, Inc. (DD) at $40.40 Transaction Date: Dec 31, 2025 | Filing ID: 000585

Alpern Robert J 🟢 acquired 34 shares (1 derivative) of AbbVie Inc. (ABBV) at $228.49 Transaction Date: Dec 31, 2025 | Filing ID: 000003

Williams Michelle LeRoux 🟢 acquired 368.0K shares (1 derivative) of ELUTIA INC. (ELUT) at $0.69 Transaction Date: Jan 01, 2026 | Filing ID: 000002

Ferguson Matthew 🟢 acquired 368.0K shares (1 derivative) of ELUTIA INC. (ELUT) at $0.69 Transaction Date: Jan 01, 2026 | Filing ID: 000002

Quaggin Susan E 🟢 acquired 68 shares (1 derivative) of AbbVie Inc. (ABBV) at $228.49 Transaction Date: Dec 31, 2025 | Filing ID: 000002

RAPP EDWARD J 🟢 acquired 147 shares (1 derivative) of AbbVie Inc. (ABBV) at $228.49 Transaction Date: Dec 31, 2025 | Filing ID: 000002

Mills C Randal 🟢 acquired 726.0K shares (1 derivative) of ELUTIA INC. (ELUT) at $0.69 Transaction Date: Jan 01, 2026 | Filing ID: 000002

Director VINOGRADOV ALEXEY ANDREEVICH 🟢 acquired 2.5K shares (1 derivative) of Xenetic Biosciences, Inc. (XBIO) at $2.17 Transaction Date: Dec 31, 2025 | Filing ID: 000104

Director Dastoor Firdaus J. 🟢 acquired 2.5K shares (1 derivative) of Xenetic Biosciences, Inc. (XBIO) at $2.17 Transaction Date: Dec 31, 2025 | Filing ID: 000103

Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

📋 James Hamilton (Officer) plans to sell 40K shares of Arrowhead (at $63.09 each, total $2.5M) Filed: Jan 05, 2026 | ID: 000582

Director Buckley Mortimer J 🟢 acquired 1.5K shares (1 derivative) of PFIZER INC (PFE) Transaction Date: Dec 31, 2025 | Filing ID: 000193

Director Echevarria Joseph 🟢 acquired 1.9K shares (1 derivative) of PFIZER INC (PFE) Transaction Date: Dec 31, 2025 | Filing ID: 000192

CAUSEY CHRISTOPHER 🟡 adjusted position in 1.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $500.01 Transaction Date: Jan 02, 2026 | Filing ID: 000001